Site icon Market Globalist

What Accelerated The Enzolytics (ENZC) Stock In Recent Trade?

At the close of the previous trading session, shares of drug development company Enzolytics Inc (OTC PINK: EZSC) shot up 15.83% to $0.6360. In contrast to the 30-day daily average trading volume of 52.15M, the stock registered a trading volume of 32.53M on Tuesday. Within the last 52-week period, its stock value varied from $0.0001 to $0.9580.

Get the hottest stocks to trade every day before the market opens 100% free. Click here now. 

What does the company do?

In addition to developing proprietary proteins, the biotechnology company aims to commercialize them for the treatment of debilitating infectious diseases. Studies have shown the ability of ITV-1 (Immune Therapeutic Vaccine-1) to efficiently treat HIV/AIDS. It is one of the company’s flagship compounds in liquid form which is comprised of Inactivated Pepsin Fraction (IPF). Being porcine pepsin extract and one of ITV-1’s most active ingredients, IPF has shown to enhance the immune system’s capability to locate and fight off infection.

Read More

What drove the stock surge?

Yesterday, Enzolytics Inc. announced the results of its in vitro study that demonstrated broad efficacy and low toxicity of the Company’s ITV-1/IPF peptide treatment, an announcement that caused the stock to rise in the Tuesday session. About the conducted study, the company shared that:

Exit mobile version